Boardroom Alpha
Boardroom Alpha
KD · Amended Current Report (Form 8-K/A) · Filed February 17, 2026

Kyndryl Holdings Inc — Amended Current Report (Form 8-K/A)

Form
8-K/A
Filed
February 17, 2026
Period
Feb 5, 2026
Ticker
KD
Accession
0001104659-26-015755
Boardroom Alpha · Filing insights

Amendment to interim CFO and Controller compensation; one-time RSU grants and cash payments, with grants scheduled March 2, 2026.

About Kyndryl Holdings Inc
Market cap
$2.9B
1Y TSR
−59.0%
3Y TSR
−6.8%
Board grade
B
Sector
Technology
CEO
Martin J Schroeter
Last annual meeting: Jul 30, 2026 · View full Kyndryl Holdings Inc profile →

 

 

  

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K/A

(Amendment No. 1)

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934


Date of report (Date of earliest event reported): February 5, 2026

 

 

Kyndryl Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

 

Delaware
(State or other jurisdiction
of incorporation)
001-40853
(Commission
File Number)
86-1185492
(I.R.S. Employer
Identification No.)

 

 

One Vanderbilt Avenue, 15th Floor
New York
, New York 10017
(Address of principal executive offices, and Zip Code)

 

855-596-3795
(Registrant’s telephone number, including area code)

 

N/A
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading symbol(s)

 

Name of each exchange on which registered

Common stock, par value $0.01 per share   KD   New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

This Form 8-K/A amends the Form 8-K filed by Kyndryl Holdings, Inc. (the “Company”) on February 9, 2026 (the “Original 8-K”). As disclosed in the Original 8-K, Harsh Chugh was appointed as Interim Chief Financial Officer and Bhavna Doegar was appointed as Interim Corporate Controller of the Company, in each case effective as of February 5, 2026. The Company is filing this Form 8-K/A to amend the Original 8-K to report certain adjustments made to the existing compensation arrangements of Mr. Chugh and Ms. Doegar in connection with their respective appointment. There are no other changes to the information contained in the Original 8-K.

 

In connection with his appointment as Interim Chief Financial Officer, Mr. Chugh will receive (i) a one-time grant of restricted stock units that will vest 6 months from the date of grant, with a grant date fair value of $500,000 based on the stock price at the close of trading on the day of grant and (ii) a supplemental monthly cash payment of $35,000.

 

In connection with her appointment as Interim Corporate Controller, Ms. Doegar, who recently joined the Company in December 2025, will receive a one-time grant of restricted stock units that will vest in full 3 years from the date of grant, with a grant date fair value of $864,000 based on the stock price at the close of trading on the day of grant.

 

Grants of restricted stock units are scheduled to occur on the Company’s next regularly scheduled quarterly grant date on March 2, 2026.

 

 

 

 

SIGNATURES

  

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: February 17, 2026

 

     
  KYNDRYL HOLDINGS, INC.
     
  By: /s/ Evan Barth
    Name:  Evan Barth
    Title:  Vice President, Associate General Counsel and Assistant Corporate Secretary

 

 

 

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Kyndryl Holdings Inc (KD)

Reference

Frequently asked questions

When did Kyndryl Holdings Inc file this 8-K/A?
Kyndryl Holdings Inc (KD) filed this Amended Current Report (Form 8-K/A) with the SEC on February 17, 2026. The accession number assigned by EDGAR is 0001104659-26-015755.
What does an 8-K/A disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Amendment to interim CFO and Controller compensation; one-time RSU grants and cash payments, with grants scheduled March 2, 2026. This is Boardroom Alpha's one-line summary of the amended current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Kyndryl Holdings Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K/A Kyndryl Holdings Inc has filed under CIK 1867072, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer